Contractile function of detrusor smooth muscle from children with posterior urethral valves - The role of fibrosis.
Bladder
Detrusor contraction
Fibrosis
Posterior urethral valves
Wnt-signalling
Journal
Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
05
05
2020
revised:
08
10
2020
accepted:
01
11
2020
pubmed:
21
11
2020
medline:
22
6
2021
entrez:
20
11
2020
Statut:
ppublish
Résumé
Posterior urethral valves (PUV) is the most common cause of congenital bladder outflow obstruction with persistent lower urinary tract and renal morbidities. There is a spectrum of functional bladder disorders ranging from hypertonia to bladder underactivity, but the aetiology of these clinical conditions remains unclear. We tested the hypothesis that replacement of detrusor muscle with non-muscle cells and excessive deposition of connective tissue is an important factor in bladder dysfunction with PUV. We used isolated detrusor samples from children with PUV and undergoing primary or secondary procedures in comparison to age-matched data from children with functionally normal bladders. In vitro contractile properties, as well as passive stiffness, were measured and matched to histological assessment of muscle and connective tissue. We examined if a major pathway for fibrosis was altered in PUV tissue samples. Isometric contractions were measured in vitro in response to either stimulation of motor nerves to detrusor or exposure to cholinergic and purinergic receptor agonists. Passive mechanical stiffness was measured by rapid stretching of the tissue and recording changes to muscle tension. Histology measured the relative amounts of detrusor muscle and connective tissue. Multiplex quantitative immunofluorescence labelling using five epitope markers was designed to determine cellular pathways, in particular the Wnt-signalling pathway, responsible for any changes to excessive deposition of connective tissue. PUV tissue showed equally reduced contractile function to efferent nerve stimulation or exposure to contractile agonists. Passive muscle stiffness was increased in PUV tissue samples. The smooth muscle:connective tissue ratio was also diminished and mirrored the reduction of contractile function and the increase of passive stiffness. Immunofluorescence labelling showed in PUV samples increased expression of the matrix metalloproteinase, MMP-7; as well as cyclin-D1 expression suggesting cellular remodelling. However, elements of a fibrosis pathway associated with Wnt-signalling were either reduced (β-catenin) or unchanged (c-Myc). The accumulation of extracellular matrix, containing collagen, will contribute to the reduced contractile performance of the bladder wall. It will also increase tissue stiffness that in vivo would lead to reduced filling compliance. Replacement of smooth muscle with fibrosis is a major contributory factor in contractile dysfunction in the hypertonic PUV bladder. This suggests that a potential strategy to restore normal contractile and filling properties is development of the effective use of antifibrotic agents.
Identifiants
pubmed: 33214068
pii: S1477-5131(20)30588-X
doi: 10.1016/j.jpurol.2020.11.001
pmc: PMC9099076
mid: NIHMS1802975
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100.e1-100.e10Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK098361
Pays : United States
Informations de copyright
Copyright © 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest The authors have no conflicts of interest with respect this submission.
Références
Kidney Int. 2017 Oct;92(4):888-899
pubmed: 28483378
PLoS One. 2010 May 04;5(5):e10456
pubmed: 20454608
J Urol. 2002 Oct;168(4 Pt 1):1615-20
pubmed: 12352467
Neurourol Urodyn. 2004;23(4):361-6
pubmed: 15227655
Pediatr Surg Int. 2002 Sep;18(5-6):438-43
pubmed: 12415375
J Pediatr Urol. 2019 Apr;15(2):154.e1-154.e9
pubmed: 30745011
Am J Pathol. 2003 May;162(5):1495-502
pubmed: 12707032
Am J Physiol Renal Physiol. 2014 Nov 1;307(9):F1072-9
pubmed: 25209864
PLoS One. 2012;7(9):e44663
pubmed: 23028576
J Pediatr Urol. 2006 Aug;2(4):254-60
pubmed: 18947618
J Urol. 1999 Nov;162(5):1840-7
pubmed: 10524945
J Cell Sci. 2008 Dec 1;121(Pt 23):3853-7
pubmed: 19020303
Semin Nephrol. 2012 May;32(3):236-43
pubmed: 22835454
Eur J Pediatr Surg. 2002 Feb;12(1):38-41
pubmed: 11967758
Am J Pathol. 2003 Apr;162(4):1271-82
pubmed: 12651619
J Urol. 1997 Sep;158(3 Pt 2):1071-4
pubmed: 9258144
BJU Int. 2013 Aug;112(4):E391-7
pubmed: 23305285
J Urol. 1990 Jul;144(1):122-6
pubmed: 2359158
PLoS One. 2017 Oct 10;12(10):e0186047
pubmed: 29016636
Cell Cycle. 2019 Nov;18(22):3137-3146
pubmed: 31550972
J Urol. 1992 Aug;148(2 Pt 2):491-6
pubmed: 1640508
Neurourol Urodyn. 1997;16(3):179-89
pubmed: 9136140
Biomed Res Int. 2015;2015:726012
pubmed: 25945342
Neurourol Urodyn. 2000;19(1):29-42
pubmed: 10602246
J Pediatr Surg. 2019 Feb;54(2):318-321
pubmed: 30528204
Biophys J. 2007 Aug 15;93(4):1255-63
pubmed: 17526569
J Urol. 1998 Oct;160(4):1518-27
pubmed: 9751406
Neurourol Urodyn. 2018 Nov;37(8):2441-2451
pubmed: 29806709
J Cell Mol Med. 2012 Jul;16(7):1533-43
pubmed: 21883887
BJU Int. 2001 May;87(7):617-22
pubmed: 11350400
Biochim Biophys Acta. 2013 Oct;1832(10):1765-75
pubmed: 23770341